161 related articles for article (PubMed ID: 28394767)
1. Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland Malignancies.
Gebhardt BJ; Ohr JP; Ferris RL; Duvvuri U; Kim S; Johnson JT; Heron DE; Clump DA
Am J Clin Oncol; 2018 Sep; 41(9):888-893. PubMed ID: 28394767
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas.
Mifsud MJ; Tanvetyanon T; Mccaffrey JC; Otto KJ; Padhya TA; Kish J; Trotti AM; Harrison LB; Caudell JJ
Head Neck; 2016 Nov; 38(11):1628-1633. PubMed ID: 27098984
[TBL] [Abstract][Full Text] [Related]
3. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.
Cheraghlou S; Schettino A; Zogg CK; Otremba MD; Bhatia A; Park HS; Osborn HA; Mehra S; Yarbrough WG; Judson BL
Laryngoscope; 2019 Apr; 129(4):883-889. PubMed ID: 30151947
[TBL] [Abstract][Full Text] [Related]
5. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
[TBL] [Abstract][Full Text] [Related]
6. Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy.
Cho JK; Lim BW; Kim EH; Ko YH; Oh D; Noh JM; Ahn YC; Baek KH; Jeong HS
Ann Surg Oncol; 2016 Dec; 23(13):4368-4375. PubMed ID: 27342828
[TBL] [Abstract][Full Text] [Related]
7. Salivary gland carcinoma (SGC) with perineural spread and/or positive resection margin - high locoregional control rates after photon (chemo) radiotherapy - experience from a monocentric analysis.
Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Putz F; Iro H; Agaimy A; Fietkau R
Radiat Oncol; 2019 Apr; 14(1):68. PubMed ID: 31014362
[TBL] [Abstract][Full Text] [Related]
8. Management and outcome of patients with malignant salivary gland tumors.
Bell RB; Dierks EJ; Homer L; Potter BE
J Oral Maxillofac Surg; 2005 Jul; 63(7):917-28. PubMed ID: 16003616
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Therapy for Salivary Gland Carcinomas.
Sayan M; Vempati P; Miles B; Teng M; Genden E; Demicco EG; Misiukiewicz K; Posner M; Gupta V; Bakst RL
Anticancer Res; 2016 Aug; 36(8):4165-70. PubMed ID: 27466526
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of lymph node density in high-grade salivary gland cancers.
Hong HR; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2015 May; 111(6):784-9. PubMed ID: 25640975
[TBL] [Abstract][Full Text] [Related]
11. Outcome and management of rare high-grade "salivary" adenocarcinoma: the important role of adjuvant (chemo)radiotherapy.
Scherl C; Haderlein M; Agaimy A; Mantsopoulos K; Koch M; Traxdorf M; Fietkau R; Grundtner P; Iro H
Strahlenther Onkol; 2019 Dec; 195(12):1050-1059. PubMed ID: 31350567
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies.
Rosenberg L; Weissler M; Hayes DN; Shockley W; Zanation A; Rosenman J; Chera B
Head Neck; 2012 Jun; 34(6):872-6. PubMed ID: 22127998
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and prognostic factors for surgery followed by modern radiation therapy in parotid gland carcinomas.
Huang BS; Chen WY; Hsieh CE; Lin CY; Lee LY; Fang KH; Tsang NM; Kang CJ; Wang HM; Chang JT
Jpn J Clin Oncol; 2016 Sep; 46(9):832-8. PubMed ID: 27317738
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of surgery followed by radiation therapy for minor salivary gland carcinomas.
Zeidan YH; Shultz DB; Murphy JD; An Y; Chan C; Kaplan MJ; Colevas AD; Kong C; Chang DT; Le QT
Laryngoscope; 2013 Nov; 123(11):2675-80. PubMed ID: 23553253
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.
Pederson AW; Salama JK; Haraf DJ; Witt ME; Stenson KM; Portugal L; Seiwert T; Villaflor VM; Cohen EE; Vokes EE; Blair EA
Head Neck Oncol; 2011 Jul; 3():31. PubMed ID: 21791072
[TBL] [Abstract][Full Text] [Related]
17. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion and extracapsular invasion are risk factors for distant recurrence after preoperative chemoradiotherapy and oesophagectomy in patients with oesophageal squamous cell carcinoma.
Hsu PK; Chien LI; Wang LC; Chou TY;
Eur J Cardiothorac Surg; 2017 Jun; 51(6):1188-1194. PubMed ID: 28329246
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemoradiotherapy versus with radiotherapy alone for locally advanced salivary gland carcinoma among older patients.
Tanvetyanon T; Fisher K; Caudell J; Otto K; Padhya T; Trotti A
Head Neck; 2016 Jun; 38(6):863-70. PubMed ID: 26340707
[TBL] [Abstract][Full Text] [Related]
20. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
